Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Self-report INH adherence measures were reliable and valid in Latino adolescents with latent tuberculosis infection.

Blumberg EJ, Hovell MF, Kelley NJ, Vera AY, Sipan CL, Berg JP.

J Clin Epidemiol. 2005 Jun;58(6):645-8.

PMID:
15878479
2.

Urine testing to monitor adherence to TB preventive therapy.

Perry S, Hovell MF, Blumberg E, Berg J, Vera A, Sipan C, Kelley N, Moser K, Catanzaro A, Friedman L.

J Clin Epidemiol. 2002 Mar;55(3):235-8.

PMID:
11864793
3.

Predictors of adherence to treatment for latent tuberculosis infection in high-risk Latino adolescents: a behavioral epidemiological analysis.

Hovell M, Blumberg E, Gil-Trejo L, Vera A, Kelley N, Sipan C, Hofstetter CR, Marshall S, Berg J, Friedman L, Catanzaro A, Moser K.

Soc Sci Med. 2003 Apr;56(8):1789-96.

PMID:
12639595
4.

Somatic complaints and isoniazid (INH) side effects in Latino adolescents with latent tuberculosis infection (LTBI).

Berg J, Blumberg EJ, Sipan CL, Friedman LS, Kelley NJ, Vera AY, Hofstetter CR, Hovell MF.

Patient Educ Couns. 2004 Jan;52(1):31-9.

PMID:
14729288
5.

A novel approach to monitoring adherence to preventive therapy for tuberculosis in adolescence.

Starr M, Sawyer S, Carlin J, Powell C, Newman R, Johnson P.

J Paediatr Child Health. 1999 Aug;35(4):350-4.

PMID:
10457290
6.

Adherence to latent tuberculosis infection therapy among latino immigrants.

Ailinger RL, Moore JB, Nguyen N, Lasus H.

Public Health Nurs. 2006 Jul-Aug;23(4):307-13.

PMID:
16817801
7.

Increasing Latino adolescents' adherence to treatment for latent tuberculosis infection: a controlled trial.

Hovell MF, Sipan CL, Blumberg EJ, Hofstetter CR, Slymen D, Friedman L, Moser K, Kelley NJ, Vera AY.

Am J Public Health. 2003 Nov;93(11):1871-7.

8.

Adherence with isoniazid for prevention of tuberculosis among HIV-infected adults in South Africa.

Szakacs TA, Wilson D, Cameron DW, Clark M, Kocheleff P, Muller FJ, McCarthy AE.

BMC Infect Dis. 2006 Jun 13;6:97.

9.

Self-report adherence measures in chronic illness: retest reliability and predictive validity.

Jerant A, DiMatteo R, Arnsten J, Moore-Hill M, Franks P.

Med Care. 2008 Nov;46(11):1134-9. doi: 10.1097/MLR.0b013e31817924e4.

PMID:
18953223
10.

In closely monitored patients, adherence in the first month predicts completion of therapy for latent tuberculosis infection.

Menzies D, Dion MJ, Francis D, Parisien I, Rocher I, Mannix S, Schwartzman K.

Int J Tuberc Lung Dis. 2005 Dec;9(12):1343-8.

PMID:
16466056
11.

Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study.

Page KR, Sifakis F, Montes de Oca R, Cronin WA, Doherty MC, Federline L, Bur S, Walsh T, Karney W, Milman J, Baruch N, Adelakun A, Dorman SE.

Arch Intern Med. 2006 Sep 25;166(17):1863-70.

PMID:
17000943
12.
13.
14.

The value of urine testing for verifying adherence to anti-tuberculosis chemotherapy in children and adults in Uganda.

Meissner PE, Musoke P, Okwera A, Bunn JE, Coulter JB.

Int J Tuberc Lung Dis. 2002 Oct;6(10):903-8.

PMID:
12365577
15.

Risk factors for failure to complete a course of latent tuberculosis infection treatment in Salvador, Brazil.

Machado A Jr, Finkmoore B, Emodi K, Takenami I, Barbosa T, Tavares M, Reis MG, Arruda S, Riley LW.

Int J Tuberc Lung Dis. 2009 Jun;13(6):719-25.

PMID:
19460247
16.

Assessment of adherence to antiretroviral therapy in perinatally HIV-infected children and youth using self-report measures and pill count.

Farley JJ, Montepiedra G, Storm D, Sirois PA, Malee K, Garvie P, Kammerer B, Naar-King S, Nichols S; PACTG P1042S Team.

J Dev Behav Pediatr. 2008 Oct;29(5):377-84. doi: 10.1097/DBP.0b013e3181856d22.

PMID:
18714204
18.

Use of the urine color test to monitor compliance with isoniazid treatment of latent tuberculosis infection.

Eidlitz-Markus T, Zeharia A, Baum G, Mimouni M, Amir J.

Chest. 2003 Mar;123(3):736-9.

PMID:
12628871
19.

Safety of treatment of latent tuberculosis infection in compensated cirrhotic patients during transplant candidacy period.

Jahng AW, Tran T, Bui L, Joyner JL.

Transplantation. 2007 Jun 27;83(12):1557-62.

PMID:
17589337
20.

[Effects of prophylaxis on QuantiFERON TB-2G responses among children].

Higuchi K, Okada K, Harada N, Mori T.

Kekkaku. 2008 Sep;83(9):603-9. Japanese.

PMID:
18979994

Supplemental Content

Support Center